We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$7.49M
Cap. Flow %
-8.61%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 45.93%
2 Miscellaneous 21.87%
3 Consumer Staples 14.06%
4 Consumer Discretionary 4.38%
5 Financials 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
K
51
DELISTED
Kellanova
K
$381K 0.44%
+5,508
New +$383K
ALKS icon
52
CALL
Alkermes
ALKS
$7.73B
$375K 0.43%
35,400
-100
-0.3% -$5.35K
CHTR icon
53
Charter Communications
CHTR
$18.1B
$373K 0.43%
1,296
-19
-1% -$5.12K
ESPR
54
DELISTED
Esperion Therapeutics
ESPR
$365K 0.42%
+29,193
New +$348K
QURE icon
55
uniQure
QURE
$3.09B
$365K 0.42%
65,158
+35,000
+116% +$235K
NBIS
56
Nebius Group N.V.
NBIS
$61.5B
$329K 0.38%
16,367
+4,367
+36% +$85.9K
TMUS icon
57
CALL
T-Mobile US
TMUS
$195B
$319K 0.37%
45,000
+10,000
+29% +$523K
BBY icon
58
Best Buy
BBY
$19B
$316K 0.36%
7,400
+3,946
+114% +$168K
ALNY icon
59
PUT
Alnylam Pharmaceuticals
ALNY
$35.6B
$303K 0.35%
13,200
-16,800
-56% -$703K
DVAX
60
PUT
DELISTED
Dynavax Technologies
DVAX
$297K 0.34%
28,000
-77,400
-73% -$567K
DPZ icon
61
Domino's
DPZ
$11.3B
$287K 0.33%
+1,800
New +$293K
PZZA icon
62
Papa John's
PZZA
$747M
$273K 0.31%
+3,191
New +$265K
MDLZ icon
63
PUT
Mondelez International
MDLZ
$78.2B
$268K 0.31%
97,200
+44,700
+85% +$1.93M
TEVA icon
64
Teva Pharmaceuticals
TEVA
$42.4B
$263K 0.3%
7,250
-24,050
-77% -$960K
VEEV icon
65
Veeva Systems
VEEV
$44.5B
$253K 0.29%
+6,219
New +$254K
TSRO
66
DELISTED
TESARO, Inc.
TSRO
$253K 0.29%
1,880
-2,165
-54% -$273K
BHC icon
67
PUT
Bausch Health
BHC
$2.45B
$252K 0.29%
45,000
+5,000
+13% +$91.7K
YELP icon
68
Yelp
YELP
$1.18B
$252K 0.29%
6,596
+5,996
+999% +$222K
CCEP icon
69
Coca-Cola Europacific Partners
CCEP
$46.7B
$251K 0.29%
+8,000
New +$282K
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$35.6B
$244K 0.28%
+6,526
New +$273K
BIIB icon
71
PUT
Biogen
BIIB
$32.6B
$241K 0.28%
11,000
-9,000
-45% -$2.67M
BABA icon
72
PUT
Alibaba
BABA
$281B
$234K 0.27%
13,100
-12,000
-48% -$1.16M
KO icon
73
Coca-Cola
KO
$379B
$231K 0.27%
5,561
-9,400
-63% -$391K
GILD icon
74
PUT
Gilead Sciences
GILD
$187B
$211K 0.24%
134,000
-30,000
-18% -$2.23M
RDUS
75
PUT
DELISTED
Radius Health, Inc.
RDUS
$188K 0.22%
+15,000
New +$714K
1 2
3
4 5

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $7.49M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.